Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
31 October 2023
Closing Date:
27 November 2023
Location(s):
PL424 Miasto Szczecin (PL Poland/POLSKA)
Description:
SUPPLY OF MEDICINES FOR THE SERVICE OF DRUG PROGRAMS FOR SPSZOZ "ZDROJE"

SUPPLY OF MEDICINES FOR THE SERVICE OF DRUG PROGRAMS FOR SPSZOZ "ZDROJE"

The subject of the contract is the conclusion of a framework agreement for the supply of medicines for the operation of drug programmes for SPSZOZ "Zdroje"

The subject of the contract is divided into 30 parts called packages. The Contracting Authority allows for the submission of partial offers. The offer should cover the entire subject of the contract in a given package.

In a given package (task), the contracting authority envisages concluding a framework agreement with one contractor due to the specificity of the subject matter of the contract.

The contracting authority provides for the award of the contract – in accordance with Article 313(1) of the PPL Act – under the terms of the contract specified in the framework agreement, without conducting a procurement procedure.

Package No. 1 - Infliximab

Infliximab

Package No. 10 - Palivizumab PR

Palivizumab PR

Package No. 11 - Etanercept

etanercept

Package No. 12 - Etanercept

etanercept

Package No. 13 - Botulinum toxin type A

Botulinum toxin type A

Package No. 14 - Adalimumab

adalimumab

Package No. 15 Adalimumab

adalimumab

Package No. 16 - Darbopoetina alfa

Darbopoetina Alpha

Package No. 17 - Tocilizumab

Tocilizumab

Package No. 18 - Aflibercept

aflibercept

Package No. 19 - Ranibizumab

ranibizumab

Package No. 2 - Immunoglobulins for use in the B 17 drug program

IMMUNOGLOBULINS FOR USE IN THE B 17 DRUG PROGRAMME

Package No. 20 - Tobramycin

Tobramycin

Package No. 21 - Baclofen inj.

Baclofen inj.

Package No. 22 - Ataluren

Ataluren

Package No. 23 - Nusinersen

Nusinersen

Package No. 24 - Lumasiranum

Lumasiranum

Package No. 25 - Eculizumab

Eculizumab

Package No. 26 - Vedolizumab

Vedolizumab

Package No. 27 - Ustekinumab

Ustekinumab

Package No. 28 - Tofacitinibum

Tofacitinibum

Package No. 29 - Ivacaftorum , Ivacaftorum + Tezacaftorum , Ivacaftorum + Tezacaftorum + Elexacaftorum, Ivacaftorum + Lumacaftorum

Ivacaftorum , Ivacaftorum + Tezacaftorum , Ivacaftorum + Tezacaftorum+Elexacaftorum,Ivacaftorum + Lumacaftorum

Package No. 3 - Secukinumab

Sekukinumab

Package No. 30 - Onasemnogenum abeparvovecum

Onasemnogenum abeparvovecum

Package No. 4 - Ivacaftorum + Lumacaftorum

Ivacaftorum + Lumacaftorum

Package No. 5 - Ravulizumab

RAVULIZUMAB

Package No. 6 - Escetaminum

Escetaminum

Package No. 7 - Substitution Treatment Program

Substitution Treatment Program

Package No. 8 Substitution Treatment Program

Substitution Treatment Program

Package No. 9 - Substitution Treatment Program

Substitution Treatment Program

Download full details as .pdf
The Buyer:
Samodzielny Publiczny Specjalistyczny Zakład Opieki Zdrowotnej "Zdroje"
CPV Code(s):
33600000 - Pharmaceutical products